Analysts predict Ocumension Therapeutics will reach breakeve...
Analysts predict Ocumension Therapeutics will reach breakeven before exhausting its cash reserves. Positive revenue growth is noted, but cash burn reduction is seen as a weak point. The company is considered well-positioned to raise more cash for growth if necessary.
Companies Like Ocumension Therapeutics (HKG:1477) Are In A Position To Invest In Growth
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment